Disc Medicine EPS IRON

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Disc Medicine's earnings per share was −$6.57 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.54.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.54	n/a	−$6.57
Q1 FY26	Mar 31, 2026	−$1.65	n/a	−$6.61
Q4 FY25	Dec 31, 2025	−$1.61	n/a	−$5.98
Q3 FY25	Sep 30, 2025	−$1.77	n/a	−$5.35
Q2 FY25	Jun 30, 2025	−$1.58	n/a	−$4.47
Q1 FY25	Mar 31, 2025	−$1.02	n/a	−$3.92
Q4 FY24	Dec 31, 2024	−$0.98	n/a	−$3.99
Q3 FY24	Sep 30, 2024	−$0.89	n/a	−$3.98
Q2 FY24	Jun 30, 2024	−$1.03	n/a	−$3.67
Q1 FY24	Mar 31, 2024	−$1.09	n/a	−$3.38
Q4 FY23	Dec 31, 2023	−$0.97	n/a	−$3.49
Q3 FY23	Sep 30, 2023	−$0.58	n/a	−$11.00

Companies in Drug Manufacturers - General nearest Disc Medicine's size, closest first, today.

Company	EPS, 12 months	Growth
IRONDisc Medicine	−$6.57
NRIXNurix Therapeutics	$2.31
OGNOrganon	$0.77	−71% a year
PBHPrestige Consumer Healthcare	$3.57	−16% a year
LQDALiquidia	$1.39
HRMYHarmony Biosciences	$3.09	−0% a year
ARQTArcutis Biotherapeutics	$0.22
INDVIndivior Pharmaceuticals	$2.78	+227% a year
ANIPANI Pharmaceuticals	$4.70
PAHCPhibro Animal Health	$2.44	+107% a year
ANABAnaptysbio	$4.57
Peer median	$2.61